Search research articles
Contact Us
Filters
Showing results (1-10 of 65) with videos related to
Page
of 7
Sort By:
Cancer Discovery
|
December 12, 2013
Teaching an old dog new tricks: drug repositioning in small cell lung cancer
Jing Wang, Lauren Averett Byers
Cancer Cell
|
July 16, 2015
Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition
C Allison Stewart, Lauren Averett Byers
Cancer
|
October 23, 2014
Small cell lung cancer: where do we go from here?
Lauren Averett Byers, Charles M Rudin
Cancer Discovery
|
September 4, 2014
A HER 1-2 punch: dual EGFR targeting deals resistance a deadly blow
Don L Gibbons, Lauren Averett Byers
Cancer Discovery
|
October 3, 2019
Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates?
Jose M Pacheco, Lauren Averett Byers
Cancer Discovery
|
January 11, 2019
Evading the STING: LKB1 Loss Leads to STING Silencing and Immune Escape in KRAS-Mutant Lung Cancers
Carminia Maria Della Corte, Lauren Averett Byers
Translational Lung Cancer Research
|
March 15, 2018
Targeting DNA damage repair in small cell lung cancer and the biomarker landscape
Triparna Sen, Carl M Gay, Lauren Averett Byers
Cancers
|
February 23, 2019
Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers
Robert J Cardnell, Lauren Averett Byers, Jing Wang
British Journal of Cancer
|
January 11, 2017
Giving AXL the axe: targeting AXL in human malignancy
Carl M Gay, Kavitha Balaji, Lauren Averett Byers
The American Journal of Medicine
|
May 4, 2005
An unexpected finding
Naomi Ko, Lauren Averett, Cynthia Brown, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 65) with videos related to
Sort By:
Page
of 7
Cancer Discovery
|
December 12, 2013
Teaching an old dog new tricks: drug repositioning in small cell lung cancer
Jing Wang, Lauren Averett Byers
Cancer Cell
|
July 16, 2015
Altering the Course of Small Cell Lung Cancer: Targeting Cancer Stem Cells via LSD1 Inhibition
C Allison Stewart, Lauren Averett Byers
Cancer
|
October 23, 2014
Small cell lung cancer: where do we go from here?
Lauren Averett Byers, Charles M Rudin
Cancer Discovery
|
September 4, 2014
A HER 1-2 punch: dual EGFR targeting deals resistance a deadly blow
Don L Gibbons, Lauren Averett Byers
Cancer Discovery
|
October 3, 2019
Temozolomide plus PARP Inhibition in Small-Cell Lung Cancer: Could Patient-Derived Xenografts Accelerate Discovery of Biomarker Candidates?
Jose M Pacheco, Lauren Averett Byers
Cancer Discovery
|
January 11, 2019
Evading the STING: LKB1 Loss Leads to STING Silencing and Immune Escape in KRAS-Mutant Lung Cancers
Carminia Maria Della Corte, Lauren Averett Byers
Translational Lung Cancer Research
|
March 15, 2018
Targeting DNA damage repair in small cell lung cancer and the biomarker landscape
Triparna Sen, Carl M Gay, Lauren Averett Byers
Cancers
|
February 23, 2019
Integrated Approaches for the Use of Large Datasets to Identify Rational Therapies for the Treatment of Lung Cancers
Robert J Cardnell, Lauren Averett Byers, Jing Wang
British Journal of Cancer
|
January 11, 2017
Giving AXL the axe: targeting AXL in human malignancy
Carl M Gay, Kavitha Balaji, Lauren Averett Byers
The American Journal of Medicine
|
May 4, 2005
An unexpected finding
Naomi Ko, Lauren Averett, Cynthia Brown, et al.
Page
of 7